You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 15, August 11, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Aortic Stenosis

A New Face for an Old Disease

Arch Intern Med. 2003;163:1769-1770.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

WHEN I WAS a second-year medical student in the 1960s, one of the first patients I was shown was a man with severe aortic stenosis secondary to rheumatic heart disease. I still remember this patient's face and the distinctive, rough, systolic ejection murmur that filled systole, obliterating the second heart sound. Since then, rheumatic cases of aortic stenosis have become rare, but severe aortic stenosis is still one of the commonest causes of valvular heart disease seen in hospitalized patients. In the more than 30 years since I saw my first patient with aortic stenosis, much has been learned concerning the pathophysiology of this condition. Indeed, there are studies currently under way seeking to alter the pathological sequence in this disease that eventually leads to aortic valve replacement.

PATHOPHYSIOLOGY OF AORTIC STENOSIS

Today, most cases of aortic stenosis are the result of bicuspid aortic valves (BAVs) or so-called calcific involvement of an originally tricuspid . . . [Full Text of this Article]


WHEN DO PATIENTS WITH BAV AND/OR AORTIC SCLEROSIS DEVELOP CLINICALLY IMPORTANT AORTIC STENOSIS?

MANAGEMENT IMPLICATIONS FOR CLINICIANS

CONCLUSIONS
Joseph S. Alpert, MD
Department of Medicine
University of Arizona Health Sciences Center
1501 N Campbell Ave
Tucson, AZ 85724-5035


RELATED LETTERS

Clarification on Heart Sound
Kenneth V. Robb
Arch Intern Med. 2004;164(1):108.
EXTRACT | FULL TEXT  

Aortic Valvular Stenosis vs Aortic Valvular Sclerosis
Tsung O. Cheng
Arch Intern Med. 2004;164(1):108-109.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pathophysiology of Aortic Valve Disease
Mihaljevic et al.
Card Surg Adult 2008;3:825-840.
FULL TEXT  

Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves
Helske et al.
Eur Heart J 2006;27:1495-1504.
ABSTRACT | FULL TEXT  

Clarification on Heart Sound
Robb
Arch Intern Med 2004;164:108-108.
FULL TEXT  

Aortic Valvular Stenosis vs Aortic Valvular Sclerosis
Cheng
Arch Intern Med 2004;164:108-109.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.